June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Inhibition of Thyroid Hormone Receptor Signaling Protects Cones in Mouse Model of Retinal Degeneration
Author Affiliations & Notes
  • Hongwei Ma
    The Department of Cell Biology, Univ of Oklahoma Health Sci Ctr, Oklahoma City, OK
  • Michael Robert Butler
    The Department of Cell Biology, Univ of Oklahoma Health Sci Ctr, Oklahoma City, OK
  • Josh Belcher
    The Department of Cell Biology, Univ of Oklahoma Health Sci Ctr, Oklahoma City, OK
  • T Michael Redmond
    Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, Bethesda, MD
  • Thomas S. Scanlan
    Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, OR
  • Xi-Qin Ding
    The Department of Cell Biology, Univ of Oklahoma Health Sci Ctr, Oklahoma City, OK
  • Footnotes
    Commercial Relationships Hongwei Ma, None; Michael Butler, None; Josh Belcher, None; T Redmond, None; Thomas Scanlan, None; Xi-Qin Ding, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5474. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Hongwei Ma, Michael Robert Butler, Josh Belcher, T Michael Redmond, Thomas S. Scanlan, Xi-Qin Ding; Inhibition of Thyroid Hormone Receptor Signaling Protects Cones in Mouse Model of Retinal Degeneration . Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5474.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Thyroid hormone (TH) signaling regulates cell proliferation, differentiation, and apoptosis. In the retina, TH signaling plays a central role in cone opsin expression and patterning. We previously showed that suppressing TH signaling by anti-thyroid treatment preserves cones in mouse models of retinal degeneration. This work investigates whether inhibition of thyroid hormone receptors (TRs) affects cone viability in retinal degeneration model mice.

Methods: The cone precursor Weri RB-1 cell line was used to determine the antagonistic activity of the TR antagonists, NH3 and 1-850. Expression levels of M-opsin, S-opsin, and TRβ2 in Weri cells following T3 treatment in the presence and absence of TR antagonists were analyzed by quantitative RT-PCR. The cone degeneration mouse model, Rpe65-/-, was used to determine whether treatment with TR antagonists protects cones. NH3 or 1-850 or vehicle was delivered to the eye by intravitreal injection at postnatal day 5 (P5), and retinas and eyes were collected on P24. 1-850 or vehicle was also injected intraperitoneally daily from P5 to P29, and retinas and eyes were collected on P30. Cone survival was evaluated by examining cone density on retinal whole mounts and retinal sections by immunohistochemical approaches.

Results: Treatment with T3 increased M-opsin expression and decreased S-opsin expression in Weri cells. The effects of T3 treatment were inhibited by NH3 and 1-850 in a dose-dependent pattern. Cone density in Rpe65-/- mice increased by about 35% following NH3 and 1-850 treatment.

Conclusions: We show that treatment with TR antagonists systemically or ocularly improved cone survival in Rpe65-/- mice. Our findings suggest that inhibition of TR signaling locally in the retina may represent a novel strategy for retinal degeneration management.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×